Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes
Rukhsana Anjum
1
,
Duraippandi Palanimuthu
1
,
WILLIAM F. LEWIS
2
,
Kyung Park
1
,
Zaklina Kovacevic
1
,
Irfan Ullah Khan
3
,
Des R Richardson
1, 4
3
Division of Cyclotron and Allied Radiopharmaceutics, INMOL Cancer Hospital, New Campus Road, Lahore 54600, Pakistan
|
Publication type: Journal Article
Publication date: 2019-07-24
scimago Q1
wos Q1
SJR: 0.958
CiteScore: 7.4
Impact factor: 4.7
ISSN: 00201669, 1520510X
PubMed ID:
31339305
Inorganic Chemistry
Physical and Theoretical Chemistry
Abstract
A series of eight bis(thiosemicarbazone) ligands and 16 of their respective copper(II) and zinc(II) complexes containing a combination of hydrogen, methyl, pyridyl, phenyl, and/or ethyl substituents at the diimine position of the ligand backbone were synthesized and characterized. The objective of this study was to identify the structure-activity relationships within a series of analogues with different substituents at the diimine position of the backbone and at the terminal N atom. The Cu(II) complexes Cu(GTSM2), Cu(GTSCM), Cu(PyTSM2), Cu(EMTSM2) and Cu(PGTSM2) demonstrated a distorted square planar geometry, while the Zn(II) complexes Zn(ATSM2)(DMSO), Zn(PyTSM2)(DMSO), and Zn(PGTSM2)(H2O) formed a distorted square pyramidal geometry. Cyclic voltammetry showed that the Cu(II) complexes display quasi-reversible electrochemistry. Of the agents, Cu(II) glyoxal bis(4,4-dimethyl-3-thiosemicarbazone) [Cu(GTSM2)] and Cu(II) diacetyl bis(4,4-dimethyl-3-thiosemicarbazone) [Cu(ATSM2)] demonstrated the greatest antiproliferative activity against tumor cells. Substitutions at the diimine position and at the terminal N atom with hydrophobic moieties markedly decreased their antiproliferative activity. Complexation of the bis(thiosemicarbazones) with Zn(II) generally decreased their antiproliferative activity, suggesting the Zn(II) complex did not act as a chaperone to deliver the ligand intracellularly, in contrast to similar bis(thiosemicarbazone) cobalt(III) complexes [King et al. Inorg. Chem.2017, 56, 6609-6623]. However, five of the eight bis(thiosemicarbazone) Cu(II) complexes maintained or increased their antiproliferative activity, relative to the ligand alone, and a mechanism of Cu-induced oxidative stress is suggested. Surprisingly, relative to normoxic growth conditions, hypoxia that is found in the tumor microenvironment decreased the antiproliferative efficacy of most bis(thiosemicarbazones) and their copper complexes. This was independent of the potential hypoxia-selectivity mediated by Cu(II/I) redox potentials. These results provide structure-activity relationships useful for the rational design of bis(thiosemicarbazone) anticancer agents.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
|
|
|
Journal of Molecular Structure
11 publications, 9.73%
|
|
|
Dalton Transactions
11 publications, 9.73%
|
|
|
Applied Organometallic Chemistry
9 publications, 7.96%
|
|
|
Molecules
5 publications, 4.42%
|
|
|
Journal of Inorganic Biochemistry
5 publications, 4.42%
|
|
|
Journal of Molecular Liquids
5 publications, 4.42%
|
|
|
Inorganic Chemistry
5 publications, 4.42%
|
|
|
Journal of Medicinal Chemistry
4 publications, 3.54%
|
|
|
European Journal of Medicinal Chemistry
4 publications, 3.54%
|
|
|
Inorganic Chemistry Communication
4 publications, 3.54%
|
|
|
Inorganica Chimica Acta
3 publications, 2.65%
|
|
|
Coordination Chemistry Reviews
3 publications, 2.65%
|
|
|
Polyhedron
3 publications, 2.65%
|
|
|
New Journal of Chemistry
3 publications, 2.65%
|
|
|
European Journal of Inorganic Chemistry
2 publications, 1.77%
|
|
|
Journal of the American Chemical Society
2 publications, 1.77%
|
|
|
International Journal of Biological Macromolecules
2 publications, 1.77%
|
|
|
Pharmacological Reviews
2 publications, 1.77%
|
|
|
Bioorganic Chemistry
2 publications, 1.77%
|
|
|
International Journal of Molecular Sciences
1 publication, 0.88%
|
|
|
Anti-Cancer Agents in Medicinal Chemistry
1 publication, 0.88%
|
|
|
Acta Crystallographica Section E: Crystallographic Communications
1 publication, 0.88%
|
|
|
Pharmaceuticals
1 publication, 0.88%
|
|
|
Journal of Chemical Sciences
1 publication, 0.88%
|
|
|
Topics in Catalysis
1 publication, 0.88%
|
|
|
BioMetals
1 publication, 0.88%
|
|
|
Scientific Reports
1 publication, 0.88%
|
|
|
Biological Trace Element Research
1 publication, 0.88%
|
|
|
Photodiagnosis and Photodynamic Therapy
1 publication, 0.88%
|
|
|
Gene Reports
1 publication, 0.88%
|
|
|
2
4
6
8
10
12
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Elsevier
44 publications, 38.94%
|
|
|
Royal Society of Chemistry (RSC)
15 publications, 13.27%
|
|
|
Wiley
14 publications, 12.39%
|
|
|
American Chemical Society (ACS)
13 publications, 11.5%
|
|
|
Springer Nature
9 publications, 7.96%
|
|
|
MDPI
7 publications, 6.19%
|
|
|
Taylor & Francis
2 publications, 1.77%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
2 publications, 1.77%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.88%
|
|
|
International Union of Crystallography (IUCr)
1 publication, 0.88%
|
|
|
Hindawi Limited
1 publication, 0.88%
|
|
|
Frontiers Media S.A.
1 publication, 0.88%
|
|
|
Pensoft Publishers
1 publication, 0.88%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.88%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
113
Total citations:
113
Citations from 2024:
40
(35%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Anjum R. et al. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes // Inorganic Chemistry. 2019. Vol. 58. No. 20. pp. 13709-13723.
GOST all authors (up to 50)
Copy
Anjum R., Palanimuthu D., Kalinowski D. S., LEWIS W. F., Park K., Kovacevic Z., Khan I. U., Richardson D. R. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes // Inorganic Chemistry. 2019. Vol. 58. No. 20. pp. 13709-13723.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/acs.inorgchem.9b01281
UR - https://doi.org/10.1021/acs.inorgchem.9b01281
TI - Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes
T2 - Inorganic Chemistry
AU - Anjum, Rukhsana
AU - Palanimuthu, Duraippandi
AU - Kalinowski, Danuta S
AU - LEWIS, WILLIAM F.
AU - Park, Kyung
AU - Kovacevic, Zaklina
AU - Khan, Irfan Ullah
AU - Richardson, Des R
PY - 2019
DA - 2019/07/24
PB - American Chemical Society (ACS)
SP - 13709-13723
IS - 20
VL - 58
PMID - 31339305
SN - 0020-1669
SN - 1520-510X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2019_Anjum,
author = {Rukhsana Anjum and Duraippandi Palanimuthu and Danuta S Kalinowski and WILLIAM F. LEWIS and Kyung Park and Zaklina Kovacevic and Irfan Ullah Khan and Des R Richardson},
title = {Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes},
journal = {Inorganic Chemistry},
year = {2019},
volume = {58},
publisher = {American Chemical Society (ACS)},
month = {jul},
url = {https://doi.org/10.1021/acs.inorgchem.9b01281},
number = {20},
pages = {13709--13723},
doi = {10.1021/acs.inorgchem.9b01281}
}
Cite this
MLA
Copy
Anjum, Rukhsana, et al. “Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.” Inorganic Chemistry, vol. 58, no. 20, Jul. 2019, pp. 13709-13723. https://doi.org/10.1021/acs.inorgchem.9b01281.
Profiles